These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34980760)

  • 1. Paraneoplastic Opsoclonus-myoclonus Syndrome with Anti-Hu and Anti-SOX-1 Antibodies after Immune-checkpoint Inhibitor Treatment Combined with Chemotherapy in a Patient with Small-cell Lung Cancer.
    Arai H; Utsu Y; Horio J; Furukawa S; Kikkawa Y
    Intern Med; 2022; 61(1):71-74. PubMed ID: 34980760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-SOX1 Antibody-positive Small-cell Lung Cancer That Triggered Opsoclonus.
    Chiko Y; Sugisaki Y; Miyoshi K; Morichika D; Beika Y; Taniguchi A; Ichihara E; Okada T
    Intern Med; 2023 Mar; 62(6):881-884. PubMed ID: 35989271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsoclonus-Ataxia Syndrome in a Patient With Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
    Farina A; Villagrán-García M; Benaiteau M; Lamblin F; Fourier A; Honnorat J; Joubert B
    Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200287. PubMed ID: 39013128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.
    Simister RJ; Ng K; Lang B; Beckles M; Chao D; McCabe DJ
    J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):344-6. PubMed ID: 20392978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small-cell carcinoma of the lung.
    Alkan A; Cenikli U; Uylaş S; Yılmaz M; Çakır T; Çetinkaya H; Kıran A; Tanrıverdi Ö
    J Oncol Pharm Pract; 2020 Jan; 26(1):209-211. PubMed ID: 30791855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic opsoclonus-myoclonus-ataxia syndrome revealing dual malignancy.
    Nasri A; Kacem I; Jerdak F; Djebara MB; Mejri N; Sidhom Y; Gargouri A; Gouider R
    Neurol Sci; 2016 Oct; 37(10):1723-5. PubMed ID: 27329274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic opsoclonus and cerebellar ataxia related to anti-Ma2 antibody: a case report.
    Mélé N; Hautefort C; Toledano A; Delattre JY; Psimaras D
    J Neurol; 2016 Feb; 263(2):405-406. PubMed ID: 26754007
    [No Abstract]   [Full Text] [Related]  

  • 8. [Small cell lung cancer complicated by opsoclonus myoclonus syndrome].
    Iwata T; Yokomura I; Ohsugi S; Uesaka A; Sekiguchi K; Nishio A
    Nihon Kokyuki Gakkai Zasshi; 2009 Nov; 47(11):1046-50. PubMed ID: 19994603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-cell Lung Carcinoma with Gastrointestinal Pseudo-obstruction as a Paraneoplastic Neurological Syndrome Elicited by an Immune Checkpoint Inhibitor.
    Saitou A; Shioya M; Nagahisa Y; Haseyama A; Niwa R; Tsuchimoto J; Chiba H
    Intern Med; 2024 Jul; 63(14):2059-2062. PubMed ID: 38044152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic opsoclonus-myoclonus syndrome as a new and single manifestation of relapsing disease in a patient with small cell lung cancer.
    Nadal E; Bruna J; Ochoa de Olza M; Antonio M; Cardenal F
    J Thorac Oncol; 2011 May; 6(5):968-9. PubMed ID: 21623271
    [No Abstract]   [Full Text] [Related]  

  • 11. Paraneoplastic Sensory Polyneuropathy Related to Anti-PD-L1-including Anticancer Treatment in a Patient with Lung Cancer.
    Morimoto T; Orihashi T; Yamasaki K; Tahara M; Kato K; Yatera K
    Intern Med; 2021 May; 60(10):1577-1581. PubMed ID: 33328400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic opsoclonus-myoclonus secondary to malignant melanoma.
    Berger JR; Mehari E
    J Neurooncol; 1999 Jan; 41(1):43-5. PubMed ID: 10222421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atezolizumab-induced cerebellar ataxia in a patient with metastatic small cell lung cancer: A case report and literature review.
    Kapagan T; Aksu F; Yuzkan S; Bulut N; Erdem GU
    J Oncol Pharm Pract; 2024 Jan; 30(1):201-205. PubMed ID: 37321205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody.
    Hersh B; Dalmau J; Dangond F; Gultekin S; Geller E; Wen PY
    Neurology; 1994 Sep; 44(9):1754-5. PubMed ID: 7936310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsoclonus-myoclonus syndrome associated with a nasopharyngeal tumor in an adult: a case report.
    Taib BG; Kinshuck AJ; Milburn-McNulty P; Fratalia L; Forsyth L; Husband D; Jones TM; Jacob A
    J Med Case Rep; 2015 Jun; 9():128. PubMed ID: 26033370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report.
    Reinecke R; Reiländer A; Seiler A; Koch C; Voss M
    BMC Neurol; 2022 Dec; 22(1):507. PubMed ID: 36581905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsoclonus-myoclonus syndrome and exaggerated startle response associated with small-cell lung cancer.
    Sotirchos ES; Dorsey ER; Tan IL; Zee DS
    Mov Disord; 2011 Aug; 26(9):1769-70. PubMed ID: 21452255
    [No Abstract]   [Full Text] [Related]  

  • 18. Opsoclonus-myoclonus paraneoplastic syndrome in nasopharyngeal carcinoma.
    Stewart KE; Zeidler M; Srinivasan D; Yeo JCL
    BMJ Case Rep; 2022 Oct; 15(10):. PubMed ID: 36288826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on opsoclonus-myoclonus syndrome in adults.
    Oh SY; Kim JS; Dieterich M
    J Neurol; 2019 Jun; 266(6):1541-1548. PubMed ID: 30483882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paraneoplastic opsoclonus-myoclonus syndrome revealing T-cell lymphoma].
    Ducrocq X; Petit J; Taillandier L; Dorvaux V; Anxionnat R; Plénat F; Vespignani H
    Presse Med; 1999 Feb; 28(7):330-3. PubMed ID: 10083874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.